A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260

https://doi.org/10.1016/0014-2999(89)90290-2Get rights and content

Abstract

L-365,260 (3R(+)-N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N′ -(3-methylphenyl)urea), interacted in a stereoselective and competitive manner with guinea pig stomach gastrin and brain cholecystokinin (CCK) receptors. The affinity of L-365,260 for both gastrin (Ki = 1.9 nM) and brain CCK-B (Ki = 2.0 nM) receptors was > 2 orders of magnitude higher than its affinity for peripheral pancreatic CCK-A receptors or various other receptors. L-365,260 exhibited a similar high affinity for brain CCK-B receptors of rats, mice and man. A somewhat lower affinity for gastrin and brain CCK-B (IC50 = 20–40 nM) receptors was observed in dog tissues. In vivo, oral administration of L-365,260 antagonized gastrin-stimulated acid secretion in mice (ED50 = 0.03 mg/kg), rats (ED50 = 0.9 mg/kg) and guinea pigs (ED50 = 5.1 mg/kg). L-365,260 did not affect basal acid secretion and did not antagonize histamine- or carbachol-stimulated acid secretion in mice. L-365,260 represents a potentially powerful new tool for investigating gastrin and brain CCK-B receptors, and possibly their role in physiology and disease.

References (19)

There are more references available in the full text version of this article.

Cited by (406)

  • Design and synthesis of novel 1,4-benzodiazepine surrogates as potential CCKA and CCKB antagonists via palladium-catalyzed three-component cascade reactions

    2018, Tetrahedron
    Citation Excerpt :

    Using identical reaction conditions than those described before, substituted and unsubstituted allenes 7 were allowed to react with aryl halides 6 and heterocycle 9a, in the presence of Pd2(dba)3 (10 mol%) and PPh3 (20 mol%) in DMF at 80 °C for 48 h. Functionalized compounds 10a-d were obtained in 65–92% yield in one pot cascade reaction (Scheme 3). X-Ray diffraction analysis of structure 10a28 also confirmed the skeleton drawn in Scheme 3. A third series of benzodiazepine-2-one analogues were prepared from 5 or 9 but employing carbon monoxide instead of allenes as relay species in the cascade processes.

  • The role of cholecystokinin receptors in the short-term control of food intake

    2013, Progress in Molecular Biology and Translational Science
  • Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y

    2012, Physiology and Behavior
    Citation Excerpt :

    Both receptors belong to the super family of G-protein coupled receptors, and couple to Gq. CCK-A has a high affinity for sulphated CCK-8 (CCK-8S), where CCK-B is equally selective for CCK-8S, non-sulphated CCK-8 (CCK-8 N), CCK-4, and CCK-5 [37–39]. Initial behavioral studies showed impairment of acquisition of active avoidance with IP administration of sulphated and non-sulphated CCK-8.

  • Synthesis and structure-activity relationship of new 1,5-dialkyl-1,5- benzodiazepines as cholecystokinin-2 receptor antagonists

    2011, Bioorganic and Medicinal Chemistry
    Citation Excerpt :

    The CCK1 receptor subtypes are involved both in the control of the gall bladder and in the digestive enzyme secretion, while the CCK2 subtypes are mainly responsible for neurotransmission and neuromodulation. In particular, during the last years, it has been demonstrated that CCK2 antagonists are targets for anxiety and panic.2–7 Many different classes of compounds have been reported as CCK2 antagonists8: 1,4-benzodiazepines3 and 1,3,4-benzotriazepines9, dipeptoids10, quinazolines11, pyrazolidinones12, quinazolinones.13

View all citing articles on Scopus
View full text